Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2018 | -18.31 Thousand USD | 42.35% |
| 2017 | -31.77 Thousand USD | 93.95% |
| 2016 | -524.88 Thousand USD | 69.31% |
| 2015 | -1.71 Million USD | -29.49% |
| 2014 | -1.32 Million USD | -199.46% |
| 2013 | -440.98 Thousand USD | -162.27% |
| 2012 | -168.14 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2019 Q2 | 234.07 USD | 112.8% |
| 2019 Q1 | 110.00 USD | 698.02% |
| 2019 Q3 | 320.03 USD | 36.72% |
| 2018 Q3 | -86.84 USD | -16.05% |
| 2018 Q4 | -18.39 USD | 78.82% |
| 2018 Q2 | -74.83 USD | 84.46% |
| 2018 Q1 | -481.54 USD | -1417.87% |
| 2018 FY | -18.31 Thousand USD | 42.35% |
| 2017 FY | -31.77 Thousand USD | 93.95% |
| 2017 Q4 | -31.72 USD | 89.63% |
| 2017 Q3 | -305.84 USD | 66.74% |
| 2017 Q2 | -919.43 USD | -101.72% |
| 2017 Q1 | -455.80 USD | 13.31% |
| 2016 Q4 | -525.78 USD | 28.75% |
| 2016 Q2 | -1176.07 USD | 39.57% |
| 2016 Q3 | -737.95 USD | 37.25% |
| 2016 FY | -524.88 Thousand USD | 69.31% |
| 2016 Q1 | -1946.06 USD | -13.94% |
| 2015 Q3 | -588.93 USD | 43.61% |
| 2015 FY | -1.71 Million USD | -29.49% |
| 2015 Q2 | -1044.42 USD | 46.7% |
| 2015 Q4 | -1708.01 USD | -190.02% |
| 2015 Q1 | -1959.49 USD | -48.38% |
| 2014 Q3 | -1387.38 USD | -242.72% |
| 2014 FY | -1.32 Million USD | -199.46% |
| 2014 Q2 | -404.81 USD | 12.79% |
| 2014 Q4 | -1320.59 USD | 4.81% |
| 2014 Q1 | -464.18 USD | -5.26% |
| 2013 Q4 | -440.98 USD | -6.39% |
| 2013 FY | -440.98 Thousand USD | -162.27% |
| 2013 Q3 | -414.48 USD | 54.89% |
| 2013 Q2 | -918.77 USD | -213.34% |
| 2013 Q1 | -293.22 USD | -74.38% |
| 2012 Q2 | -353.92 USD | 0.0% |
| 2012 Q3 | -541.76 USD | -53.07% |
| 2012 Q4 | -168.14 USD | 68.96% |
| 2012 FY | -168.14 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 42.79 Million USD | 100.043% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 102.943% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 92.662% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 10.241% |
| Qrons Inc. | 351.42 Thousand USD | 105.212% |
| Rebus Holdings, Inc. | 305 Thousand USD | 106.006% |
| Skye Bioscience, Inc. | -5.72 Million USD | 99.68% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 99.709% |
| Adynxx, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -1298.321% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 100.042% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 192.203% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 100.324% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 100.116% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 100.445% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 104.558% |
| SQZ Biotechnologies Company | -36.23 Million USD | 99.949% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 100.817% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 101.976% |
| Mesoblast Limited | 55.85 Million USD | 100.033% |
| Marizyme, Inc. | 18.56 Million USD | 100.099% |
| Genus plc | 190.6 Million USD | 100.01% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 100.819% |
| Pharming Group N.V. | 109.8 Million USD | 100.017% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 102.129% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 101.509% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 102.694% |
| ContraFect Corporation | -6.02 Million USD | 99.696% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 113.605% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 101.585% |
| IMV Inc. | 7.67 Million USD | 100.239% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 100.333% |
| MultiCell Technologies, Inc. | 90.04 USD | 20444.291% |
| ONE Bio Corp. | 9.04 Million USD | 100.203% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 97.504% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 100.141% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 101.339% |
| Q BioMed Inc. | 4.06 Million USD | 100.451% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 100.06% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 101.818% |
| Biomind Labs Inc. | 711.4 Thousand USD | 102.575% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 100.03% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 100.916% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 100.143% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 105.092% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 113.103% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 100.832% |
| GB Sciences, Inc. | 1.74 Million USD | 101.048% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 90.033% |
| HST Global, Inc. | 96.79 Thousand USD | 118.925% |
| CSL Limited | 10.52 Billion USD | 100.0% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 108.883% |
| Halberd Corporation | 144.72 Thousand USD | 112.657% |
| Enzolytics Inc. | 981.65 Thousand USD | 101.866% |
| Agentix Corp. | 37.63 Thousand USD | 148.678% |
| Resverlogix Corp. | 6.45 Million USD | 100.284% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 97.279% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 99.999% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 99.961% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 100.259% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 100.676% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 99.793% |
| AVAX Technologies, Inc. | -5.9 Million USD | 99.69% |
| Zenith Capital Corp. | 10.06 Thousand USD | 282.015% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.998% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 109.139% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 100.768% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 111.135% |
| Kadimastem Ltd | -253.1 Thousand USD | 92.763% |
| Helix BioMedix, Inc. | -2.57 Million USD | 99.287% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 100.09% |
| BioStem Technologies, Inc. | 4.47 Million USD | 100.41% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 109.102% |
| LadRx Corporation | -2.03 Million USD | 99.101% |
| Cell Source, Inc. | 9.23 Million USD | 100.198% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 102.884% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 102.884% |
| NovAccess Global Inc. | 2.17 Million USD | 100.841% |
| Affymax, Inc. | -5.59 Million USD | 99.673% |
| Itoco Inc. | 228.3 Thousand USD | 108.023% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 113.47% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 100.37% |
| Mobile Lads Corp. | 484.23 Thousand USD | 103.783% |
| CytoDyn Inc. | 20.26 Million USD | 100.09% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -2731.221% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -97.641% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 100.238% |
| SYBLEU INC | 473.71 Thousand USD | 103.867% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 100.411% |
| International Stem Cell Corporation | 2.59 Million USD | 100.707% |
| Bioxytran, Inc. | 1.89 Million USD | 100.965% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 129.35% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 100.84% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 100.533% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 100.214% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 102.371% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 98.535% |
| Neutra Corp. | 52.18 Thousand USD | 135.101% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 99.264% |
| PureTech Health plc | -167.19 Million USD | 99.989% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 92.52% |
| IXICO plc | -4.44 Million USD | 99.588% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 100.139% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 100.033% |
| CSL Limited | 10.52 Billion USD | 100.0% |
| Cellectis S.A. | -43.81 Million USD | 99.958% |